FDA authorizes additional omicron Covid shots for seniors and people with weak immune systemsCNBC • 04/18/23
Moderna Crumbles As Cancer Vaccine Data Shows A 'Longish And Complex' RoadInvestors Business Daily • 04/17/23
Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following CAccesswire • 04/16/23
Is Moderna Stock A Buy On A New Suite Of Vaccines Targeting Flu, RSV, Cancer?Investors Business Daily • 04/14/23
Moderna, Legend Biotech advanced to the major league from the minors. But how do you spot a rookie company ready to move to the ‘show'?Proactive Investors • 04/14/23